awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34181849-3F65340F-E00E-4BF5-88ED-CF5C784BB6E6
Q34181849-3F65340F-E00E-4BF5-88ED-CF5C784BB6E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34181849-3F65340F-E00E-4BF5-88ED-CF5C784BB6E6
Insulin action enhancers for the management of type 2 diabetes mellitus.
P2860
Q34181849-3F65340F-E00E-4BF5-88ED-CF5C784BB6E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34181849-3F65340F-E00E-4BF5-88ED-CF5C784BB6E6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2cbf14db12cedc30eecb50c458daee7a5a40fd8f
P2860
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.